Shudong Wang, PhD

University of South Australia, Australia

Poster(s):

• 1310 - Evaluation of two novel Cyclin Dependent Kinase 9 inhibitors for the treatment of Myeloid Cell Leukaemia 1 (MCL1) high Chronic Lymphocytic Leukaemia